The acquired immunodeficiency syndrome (AIDS): an update

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Acquired immunodeficiency syndrome (AIDS) is a critical global health issue characterized by severe defects in cell-mediated immunity.
• This immune deficiency renders patients susceptible to opportunistic infections and rare cancers, such as Kaposi's sarcoma.
• The disease is caused by a specific retrovirus, identified as HTLV-III/lymphadenopathy-associated virus.

Purpose of the Study:

• To describe the characteristics of Acquired immunodeficiency syndrome (AIDS).
• To identify the causative agent of AIDS and its mode of transmission.
• To highlight the severity and lack of effective treatments for AIDS.

Main Methods:

• The study describes the clinical characteristics of AIDS, including opportunistic infections and neoplasms.
• It identifies the human retrovirus responsible (HTLV-III/lymphadenopathy-associated virus) and its target cells (T4 helper/inducer subset).
• Transmission routes (sexual, blood, blood products) and epidemiological data (global spread, US cases as of Sept 1984) are discussed.

Main Results:

• AIDS is caused by a retrovirus (HTLV-III/LAV) that infects T4 cells, leading to profound immune defects.
• The virus is transmitted sexually and through blood/blood products, affecting specific risk groups.
• As of September 1984, approximately 6,000 cases were reported in the USA, with the disease prevalent worldwide.

Conclusions:

• There is currently no effective treatment for AIDS, and the mortality rate for advanced cases approaches 100%.
• The recent isolation of the causative agent offers hope for the future development of effective therapies and vaccines.
• Continued research is crucial for understanding and combating this devastating disease.